Financial Daily from THE HINDU group of publications
Saturday, Dec 10, 2005


News
Features
Stocks
Shipping
Archives
Google

Group Sites

Industry & Economy - Pharmaceuticals


Indian cos in WHO pre-qualification list for vaccines

Our Bureau

New Delhi , Dec 9

SOME Indian companies such as Bharat Biotech, Shanta Biotech, Panacea Biotec and Serum Institute are now part of the World Health Organisation's pre-qualification list.

Speaking to newspersons, Mr Alan Court, UNICEF Representative, said, "This will make these companies eligible to export the pre-qualified vaccines to other countries.

These could also be used for Global Alliance for Vaccines and Immunisation (GAVI) programmes in different parts of the world."

After the third GAVI Partners' meeting, Dr Julian Lob-Levyt, Executive Secretary, GAVI, said, "The meeting anticipated that the price of saving an additional 10 million lives between 2006-2015 by vaccination is estimated at $35 billion. We estimate a shortfall of $10 billion-15 billion."

He said that the gap could be filled through innovative financing mechanism.

For instance, six European nations have agreed to support the new International Finance Facility for Immunisation (IFFIm), which will be launched next year.

The donor Governments would pledge money for a period of 20 years that would enable IFFIm to raise money from the market by floating bonds.

This is expected to provide $400 million each year for the next 10 years.

While one third of $35 billion would be utilised to purchase vaccines, about $20 billion would be utilised for strengthening delivery mechanisms.

Currently about $2.5 billion is spent on immunisation programmes in the poorest countries.

This would have to be increased to $3.5 billion by 2010 and raised further to $4 billion by 2015.

India would get $100 million from GAVI during the next five years for its immunisation programme.

GAVI is also planning to increase the coverage of vaccines from the current basket of six by including newer vaccines.

Mr Court said, "Our aim is to reach more children and adopt an integrated approach like insecticide treated mosquito nets alongwith measles vaccine and giving Vitamin A supplements with polio drops so that they could reach poorest of poor in the developing world."

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

More Stories on : Pharmaceuticals



Stories in this Section
TN on alert as `Fanoos' heads for coast


PM to look into EPF interest rate issue
ABN Amro salutes `earth heroes'
NPA recovery will benefit all: Mid-year review
Inflation up on costlier food, manufactured items
Mineral policy to help boost Jharkhand's economy
`Follow Bengal model development strategy'
`New tech vital for pump sector'
Asia Cryo-Cell, SRMC to set up research centre
States express reservations about dual pricing of LPG, kerosene
Indian cos in WHO pre-qualification list for vaccines
MESCom cuts distribution losses to 13 pc
Beer: No more a seasonal drink?
BBC's proposal for 20% stake in Radio MidDay okayed
Aerospace varsity planned in Bangalore
US supports Indian involvement in ITER project
Women guides
WTO Ministerial: House panel presents list of dos and don'ts
BEFI call on WTO Ministerial
National Design Policy to be unveiled in January — `Designed in India' label to assure quality
PM urges unions to respond to changing times
New era of economic interaction
On the summit
Overcoming connectivity challenge
India on the cusp of FDI take-off
`A platform to boost biz opportunities'
Help varsities update syllabus, ICAI told
`India, China to dominate global working force'
IAF air show on Sunday, Monday
I-T Dept keeping tabs on high-value transactions
15 lakh t soyameal contracted for exports
Govt approves Rs 9,870-cr Tsunami package
Global ayurveda meet begins
Golden jubilee
Kerala Tourism bags award


The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | The Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2005, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line